| Artificial skin in perspective: concepts and applications CA Brohem, LB da Silva Cardeal, M Tiago, MS Soengas, ... Pigment cell & melanoma research 24 (1), 35-50, 2011 | 324 | 2011 |
| Vemurafenib resistance increases melanoma invasiveness and modulates the tumor microenvironment by MMP-2 upregulation S Sandri, F Faião-Flores, M Tiago, PC Pennacchi, RR Massaro, ... Pharmacological Research 111, 523-533, 2016 | 95 | 2016 |
| Fibroblasts protect melanoma cells from the cytotoxic effects of doxorubicin M Tiago, EM de Oliveira, CA Brohem, PC Pennacchi, RD Paes, RB Haga, ... Tissue engineering Part A 20 (17-18), 2412-2421, 2014 | 55 | 2014 |
| Basic Red 51, a permitted semi-permanent hair dye, is cytotoxic to human skin cells: Studies in monolayer and 3D skin model using human keratinocytes (HaCaT) TB Zanoni, M Tiago, F Faião-Flores, SB de Moraes Barros, A Bast, ... Toxicology letters 227 (2), 139-149, 2014 | 48 | 2014 |
| Synthetic Lethal Screens Reveal Cotargeting FAK and MEK as a Multimodal Precision Therapy for GNAQ-Driven Uveal Melanoma JS Paradis, M Acosta, R Saddawi-Konefka, A Kishore, S Lubrano, ... Clinical Cancer Research 27 (11), 3190-3200, 2021 | 47 | 2021 |
| Proteasome inhibition and ROS generation by 4‐nerolidylcatechol induces melanoma cell death CA Brohem, RR Massaro, M Tiago, CE Marinho, MG Jasiulionis, ... Pigment cell & melanoma research 25 (3), 354-369, 2012 | 46 | 2012 |
| CADM1 is a TWIST1-regulated suppressor of invasion and survival EJ Hartsough, MB Weiss, SA Heilman, TJ Purwin, CH Kugel III, ... Cell death & disease 10 (4), 281, 2019 | 40 | 2019 |
| Targeting SOX10-deficient cells to reduce the dormant-invasive phenotype state in melanoma C Capparelli, TJ Purwin, MK Glasheen, S Caksa, M Tiago, N Wilski, ... Nature communications 13 (1), 1381, 2022 | 37 | 2022 |
| Apoptosis through Bcl-2/Bax and cleaved caspase up-regulation in melanoma treated by boron neutron capture therapy F Faiao-Flores, PRP Coelho, JD Toledo Arruda-Neto, SS Maria-Engler, ... PLoS One 8 (3), e59639, 2013 | 30 | 2013 |
| A natural bacterial-derived product, the metalloprotease arazyme, inhibits metastatic murine melanoma by inducing MMP-8 cross-reactive antibodies FV Pereira, CA Ferreira-Guimaraes, T Paschoalin, JAB Scutti, FM Melo, ... PloS one 9 (4), e96141, 2014 | 24 | 2014 |
| The next‐generation BET inhibitor, PLX51107, delays melanoma growth in a CD8‐mediated manner DA Erkes, CO Field, C Capparelli, M Tiago, TJ Purwin, I Chervoneva, ... Pigment cell & melanoma research 32 (5), 687-696, 2019 | 23 | 2019 |
| Targeting BRD/BET proteins inhibits adaptive kinome upregulation and enhances the effects of BRAF/MEK inhibitors in melanoma M Tiago, C Capparelli, DA Erkes, TJ Purwin, SA Heilman, AC Berger, ... British journal of cancer 122 (6), 789-800, 2020 | 20 | 2020 |
| BET inhibition modifies melanoma infiltrating T cells and enhances response to PD-L1 blockade N Nikbakht, M Tiago, DA Erkes, I Chervoneva, AE Aplin The Journal of investigative dermatology 139 (7), 1612, 2019 | 16 | 2019 |
| SOX10 requirement for melanoma tumor growth is due, in part, to immune-mediated effects SR Rosenbaum, M Tiago, S Caksa, C Capparelli, TJ Purwin, G Kumar, ... Cell reports 37 (10), 2021 | 13 | 2021 |
| Melatonin inhibits human melanoma cells proliferation and invasion via cell cycle arrest and cytoskeleton remodeling ACR Moreno, R de Freitas Saito, M Tiago, RR Massaro, RL Pagni, ... Melatonin Research 3 (2), 194-209, 2020 | 13 | 2020 |
| A Genome-Wide Screen Identifies PDPK1 as a Target to Enhance the Efficacy of MEK1/2 Inhibitors in NRAS Mutant Melanoma W Cai, MQ Nguyen, NA Wilski, TJ Purwin, M Vernon, M Tiago, AE Aplin Cancer research 82 (14), 2625-2639, 2022 | 12 | 2022 |
| Indoleamine 2, 3-dioxygenase in melanoma progression and BRAF inhibitor resistance S Sandri, LRM Watanabe, EA de Oliveira, F Faiao-Flores, S Migliorini, ... Pharmacological Research 159, 104998, 2020 | 11 | 2020 |
| Raptinal induces gasdermin E–dependent pyroptosis in naïve and therapy-resistant melanoma M Vernon, NA Wilski, D Kotas, W Cai, D Pomante, M Tiago, ES Alnemri, ... Molecular Cancer Research 20 (12), 1811-1821, 2022 | 10 | 2022 |
| Activation of CD8+ T Cells Contributes to Antitumor Effects of CDK4/6 Inhibitors plus MEK Inhibitors JLF Teh, DA Erkes, PF Cheng, M Tiago, NA Wilski, CO Field, ... Cancer immunology research 8 (9), 1114-1121, 2020 | 10 | 2020 |
| Pyruvate dehydrogenase inactivation causes glycolytic phenotype in BAP1 mutant uveal melanoma A Han, V Chua, U Baqai, TJ Purwin, N Bechtel, E Hunter, M Tiago, ... Oncogene 41 (8), 1129-1139, 2022 | 9 | 2022 |
Silvya Stuchi Maria-EnglerFull Professor of School of Pharmaceutical Sciences, University of São PauloVerified email at usp.br
